HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Selma Ugurel Selected Research

Selma Ugurel Research Topics

Disease

95Melanoma (Melanoma, Malignant)
04/2022 - 08/2002
56Neoplasms (Cancer)
04/2022 - 01/2003
17Merkel Cell Carcinoma
03/2022 - 05/2006
15Neoplasm Metastasis (Metastasis)
03/2022 - 01/2003
15Skin Neoplasms (Skin Cancer)
01/2022 - 03/2007
8Disease Progression
05/2021 - 08/2002
4Brain Neoplasms (Brain Tumor)
01/2022 - 09/2008
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2020 - 03/2007
3Uveal melanoma
01/2022 - 06/2003
3Dermatofibrosarcoma
01/2017 - 03/2007
2Myasthenia Gravis
03/2021 - 01/2019
2Fibrosis (Cirrhosis)
01/2021 - 01/2014
2Inflammation (Inflammations)
01/2021 - 01/2021
2Autoimmune Diseases (Autoimmune Disease)
01/2017 - 07/2006
2Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
01/2014 - 07/2010
1Cardiotoxicity
01/2022
1Necrosis
01/2022
1Cytokine Release Syndrome
10/2021
1Testicular Neoplasms (Testicular Cancer)
06/2021
1Transverse Myelitis (Necrotizing Myelitis)
03/2021
1Brachial Plexus Neuritis (Parsonage Turner Syndrome)
03/2021
1Headache (Headaches)
03/2021
1Hypophysitis
03/2021
1Neck Pain (Cervicalgia)
03/2021
1Guillain-Barre Syndrome
03/2021
1Diabetes Mellitus
01/2021
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2021
1Exanthema (Rash)
01/2021
1Gastritis
01/2021
1Infections
01/2021
1Ketosis
01/2021
1Neutropenia
01/2021
1Pancreatitis
01/2021

Drug/Important Bio-Agent (IBA)

35Immune Checkpoint InhibitorsIBA
03/2022 - 01/2016
19Biomarkers (Surrogate Marker)IBA
04/2022 - 08/2002
15Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2022 - 02/2007
14NivolumabIBA
03/2022 - 01/2016
14IpilimumabIBA
03/2022 - 11/2016
12pembrolizumabIBA
04/2022 - 01/2016
9AntibodiesIBA
01/2022 - 05/2008
9Phosphotransferases (Kinase)IBA
05/2020 - 08/2004
7DNA (Deoxyribonucleic Acid)IBA
07/2017 - 07/2005
6Pharmaceutical PreparationsIBA
01/2021 - 01/2003
6Imatinib Mesylate (Gleevec)FDA Link
01/2017 - 03/2007
5Adenosine Triphosphate (ATP)IBA
09/2017 - 01/2003
4VemurafenibIBA
01/2021 - 01/2014
4Programmed Cell Death 1 ReceptorIBA
01/2020 - 01/2017
4Proteins (Proteins, Gene)FDA Link
01/2020 - 08/2005
4ParaffinIBA
07/2017 - 04/2007
3AntigensIBA
06/2021 - 06/2004
3InterferonsIBA
01/2020 - 09/2008
3Monoclonal AntibodiesIBA
01/2020 - 07/2016
3Dacarbazine (DIC)FDA LinkGeneric
09/2017 - 09/2008
3Formaldehyde (Formol)FDA Link
07/2017 - 01/2014
3Histocompatibility Antigens Class IIBA
01/2017 - 06/2004
3Indicators and Reagents (Reagents)IBA
08/2009 - 08/2002
2avelumabIBA
03/2022 - 07/2021
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2022 - 01/2021
2trametinibIBA
01/2022 - 01/2018
2Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
10/2021 - 01/2017
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
11/2020 - 01/2020
2Messenger RNA (mRNA)IBA
01/2020 - 01/2014
2Histone Deacetylases (Histone Deacetylase)IBA
06/2019 - 02/2006
2Biological ProductsIBA
01/2019 - 01/2018
2dabrafenibIBA
01/2018 - 01/2014
2denileukin diftitox (Ontak)FDA Link
01/2014 - 07/2010
2Paclitaxel (Taxol)FDA LinkGeneric
03/2013 - 03/2012
2LigandsIBA
02/2013 - 08/2009
2Peptides (Polypeptides)IBA
11/2012 - 06/2007
2Tumor Biomarkers (Tumor Markers)IBA
07/2009 - 12/2005
2Drug CombinationsIBA
09/2006 - 06/2003
2HLA-DR Antigens (HLA-DR)IBA
06/2004 - 08/2002
1Peptide Receptors (Peptide Receptor)IBA
03/2022
1Radioisotopes (Radionuclides)IBA
03/2022
1Deoxyglucose (2 Deoxy D glucose)IBA
02/2022
1Hemoglobins (Hemoglobin)IBA
01/2022
1encorafenibIBA
10/2021
1binimetinibIBA
10/2021
1Creatine Kinase (Creatine Phosphokinase)IBA
10/2021
1TransferasesIBA
10/2021
1Anti-Bacterial Agents (Antibiotics)IBA
01/2021
1Dipyrone (Metamizole)IBA
01/2021
1Colony-Stimulating Factors (Colony Stimulating Factor)IBA
01/2021
1C-PeptideIBA
01/2021
1Blood Glucose (Blood Sugar)IBA
01/2021
1dimemorfan (AT 17)IBA
01/2021
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2021
1Antiviral Agents (Antivirals)IBA
01/2021
1cyclopropapyrroloindoleIBA
01/2021
1cobimetinibIBA
01/2021
1Lipase (Acid Lipase)FDA Link
01/2021
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2021

Therapy/Procedure

67Therapeutics
04/2022 - 08/2002
15Immunotherapy
04/2022 - 05/2008
12Drug Therapy (Chemotherapy)
10/2017 - 01/2003
7Radiotherapy
03/2022 - 04/2007
3Aftercare (After-Treatment)
03/2021 - 04/2007
2Combination Drug Therapy (Combination Chemotherapy)
09/2017 - 04/2007
2Palliative Care (Palliative Therapy)
06/2008 - 01/2007
1Withholding Treatment
05/2021